CINA CHEST vs Lung Density Analysis

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CINA CHEST

by Avicenna.AI

Lung Density Analysis

by 4DMedical

AI Verdict

CINA CHEST is designed for rapid triage and notification of acute, life-threatening conditions like Pulmonary Embolism and Aortic Dissection in emergency settings. In contrast, IMBIO's Lung Density Analysis focuses on the quantitative assessment and 3D visualization of chronic lung diseases such as COPD and emphysema, aiding in diagnosis and long-term management. While both utilize AI for chest CT analysis, their distinct clinical applications make them complementary rather than direct competitors.

Choose CINA CHEST if…

Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for acute, life-threatening chest conditions such as Pulmonary Embolism (PE) and Aortic Dissection (AD) in an emergency or high-volume setting. This tool is ideal for streamlining workflow and prioritizing critical cases on CT angiography scans to ensure timely intervention.

View CINA CHEST →

Choose Lung Density Analysis if…

Choose Lung Density Analysis if your focus is on the detailed quantitative assessment and 3D visualization of chronic lung conditions like COPD and emphysema from CT scans. This tool is best suited for aiding in the diagnosis, management, and monitoring of disease progression, particularly in pulmonology or lung cancer screening programs where comprehensive reports and patient-centered insights are crucial.

View Lung Density Analysis →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CINA CHEST	Lung Density Analysis
Pricing	Subscription-based	Unknown
Deployment	Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker)	Unknown
FDA Status	K210237 AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools prioritize ease of use and integration into existing radiology workflows. CINA CHEST offers rapid alerts and operates as a standalone web application, providing results within minutes. Lung Density Analysis features automated workflows, 3D visualization integrated with PACS, and patient-centered reports, also delivering results quickly.

Clinical Value

Tie

Both tools offer significant clinical value in their respective domains. CINA CHEST provides rapid and accurate triage for life-threatening conditions like PE and AD, supported by strong performance metrics in clinical studies. Lung Density Analysis delivers comprehensive quantitative analysis and 3D visualization for chronic lung diseases, aiding in diagnosis, management, and personalized care, also backed by validation.

Pricing & Value

Tie

Neither company publicly discloses specific pricing details, instead opting for a 'contact for pricing' or 'subscription-based; details available upon request' model. Without transparent pricing information, it is not possible to objectively compare the value proposition of the two tools.

Enterprise Readiness

Tie

Both tools demonstrate robust enterprise readiness. CINA CHEST is FDA-cleared with a specific K number (k210237), states HIPAA compliance, and offers flexible deployment options including cloud, on-premise, and virtualized environments. Lung Density Analysis also holds FDA clearance (K141069), confirms HIPAA compliance, and provides diverse deployment options including PACS integration, AI marketplaces, and on-premise hosting.

Innovation

Lung Density Analysis

While both leverage AI, Lung Density Analysis exhibits a deeper level of innovation in quantitative imaging. Its patented Parametric Response Mapping (PRM) technology, Imbio Noise Reduction Technology (NRT), and comprehensive 3D visualization for detailed phenotyping of chronic lung diseases, including mapping normal lung, air-trapping, and emphysema, offer more specialized and advanced analytical capabilities beyond rapid triage.

Support & Docs

Lung Density Analysis

IMBIO provides clear and readily accessible support resources, including dedicated phone lines, email, an online case submission form, and publicly available user manuals for Lung Density Analysis. In contrast, specific details regarding customer support channels or comprehensive documentation for CINA CHEST were not readily found in the provided information or web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CINA CHEST	Lung Density Analysis
Primary Function/Purpose	AI-powered radiological triage and notification software for rapid detection and prioritization of life-threatening chest conditions.	AI-driven medical imaging software that provides quantitative analysis and 3D visualization of lung conditions, aiding in the diagnosis and management of diseases.
Conditions Detected/Analyzed	Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans.	Emphysema, COPD, Asthma, BOS, and general lung conditions from CT scans; validated for low-dose CT scans in lung cancer screening.
Target Specialties	Cardiology, Emergency Medicine, Radiology	Pulmonology, Radiology
Key Analytical Capabilities	Radiological computer-aided triage and notification, flags and communicates suspected positive findings, utilizes artificial intelligence (deep learning algorithms), operates as a standalone web application, provides notifications with compressed preview images.	Automated detection, visualization, and quantification of emphysema; validated for low-dose CT scans; patient-centered LungMapu2122 report; fully automated quantitative analysis and 3D visualization to PACS; Imbio Noise Reduction Technology (NRT); mapping of normal lung, air-trapping, and emphysema (Functional LDA); advanced density analysis for COPD, Asthma, BOS; quantitative reports with coronal, axial, sagittal visuals and bar charts.

Videos

Demos, reviews, and walkthroughs featuring CINA CHEST and Lung Density Analysis.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

CINA CHEST is designed for rapid radiological triage and notification of life-threatening conditions such as Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. IMBIO's Lung Density Analysis provides quantitative analysis and 3D visualization of lung conditions, including COPD, emphysema, air-trapping, asthma, and BOS, from CT scans.

What types of CT scans are compatible with each software?

CINA CHEST is specifically indicated for use with Chest and Thoraco-abdominal CT angiography scans. IMBIO's Lung Density Analysis works with CT scans, and is validated for low-dose CT scans, making it suitable for lung cancer screening programs.

How do the functionalities of these tools differ in supporting clinical workflow?

CINA CHEST assists workflow triage by flagging and communicating suspected positive findings of PE and AD, providing rapid notifications. IMBIO's Lung Density Analysis offers automated detection, visualization, and quantification of lung conditions, generating detailed reports and 3D visualizations that can be integrated into PACS for personalized patient care.

Which medical specialties are these tools primarily designed to support?

CINA CHEST is primarily designed to support Cardiology, Emergency Medicine, and Radiology, focusing on acute, time-sensitive chest conditions. IMBIO's Lung Density Analysis is mainly for Pulmonology and Radiology, aiding in the diagnosis and management of chronic lung diseases.

What kind of output or reports do these tools generate?

CINA CHEST provides notifications with compressed preview images for informational purposes, flagging suspected positive findings of PE and AD. IMBIO's Lung Density Analysis generates fully automated quantitative analysis, 3D visualizations, and patient-centered reports, such as the LungMapu2122 report, which include coronal, axial, sagittal visuals, and bar charts.